Identification of somatic JAK1 mutations in patients with acute myeloid leukemia (Q36591400)

15 August 2017

Identification of somatic JAK1 mutations in patients with acute myeloid leukemia (English)

1 reference

15 August 2017

1 reference

18

Elaine R Mardis

1 reference

15 August 2017

4

Daved H Fremont

1 reference

15 August 2017

13

Timothy A Graubert

1 reference

15 August 2017

7

Rhonda E Ries

1 reference

15 August 2017

9

Michael D McLellan

1 reference

15 August 2017

17

Rakesh Nagarajan

1 reference

15 August 2017

12

Jacqueline E Payton

1 reference

15 August 2017

21

Michael H Tomasson

1 reference

15 August 2017

3

Vesselin Mitaksov

1 reference

15 August 2017

Zhifu Xiang

1

1 reference

15 August 2017

Yu Zhao

2

1 reference

15 August 2017

Yumi Kasai

5

1 reference

15 August 2017

AnnaLynn Molitoris

6

1 reference

15 August 2017

Tracie L Miner

8

1 reference

15 August 2017

John F DiPersio

10

1 reference

15 August 2017

Daniel C Link

11

1 reference

15 August 2017

Mark Watson

14

1 reference

15 August 2017

William Shannon

15

1 reference

15 August 2017

Sharon E Heath

16

1 reference

15 August 2017

Richard K Wilson

19

1 reference

15 August 2017

Timothy J Ley

20

1 reference

15 August 2017

language of work or name

English

0 references

publication date

26 December 2007

1 reference

15 August 2017

1 reference

15 August 2017

111

1 reference

15 August 2017

4809-4812

1 reference

15 August 2017

9

1 reference

Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

The JAK-STAT signaling pathway: input and output integration

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

Interferons, immunity and cancer immunoediting

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

A gain-of-function mutation of JAK2 in myeloproliferative disorders

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

Signal transducer and activator of transcription proteins in leukemias.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

Enhanced genome annotation using structural profiles in the program 3D-PSSM

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

An amino acid substitution in the Drosophila hopTum-l Jak kinase causes leukemia-like hematopoietic defects.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

Activating alleles of JAK3 in acute megakaryoblastic leukemia

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

The Janus protein tyrosine kinases in hematopoietic cytokine signaling

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2343608

10.1182/BLOOD-2007-05-090308

20 September 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

1 reference